Dewpoint

Dewpoint Therapeutics is a Boston-based biotechnology company, founded in 2018, that pioneers drug discovery based on biomolecular condensates — the membraneless compartments inside cells whose formation and dysregulation underlie many diseases. Its condensate platform combines cell biology, high-throughput screening, and machine learning to identify condensate-modulating drugs (c-mods) against previously undruggable targets across oncology, neurodegeneration, and virology. Dewpoint is backed by SoftBank Vision Fund 2 and completed a $150M Series C in 2022. The company operates as a therapeutics developer and, as of this profile, exposes no public developer API, documentation, or developer portal; this entry captures its identity within the API Evangelist network.

Dewpoint is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotech, Drug Discovery, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub

2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

Company Health Tech Biotech Drug Discovery Pharmaceuticals Life Sciences Machine-Learning

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 2.2/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 0.0 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/dewpoint: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: dewpoint
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/dewpoint.png
name: Dewpoint
description: Dewpoint Therapeutics is a Boston-based biotechnology company, founded in 2018, that pioneers drug discovery
  based on biomolecular condensates — the membraneless compartments inside cells whose formation and dysregulation underlie
  many diseases. Its condensate platform combines cell biology, high-throughput screening, and machine learning to identify
  condensate-modulating drugs (c-mods) against previously undruggable targets across oncology, neurodegeneration, and virology.
  Dewpoint is backed by SoftBank Vision Fund 2 and completed a $150M Series C in 2022. The company operates as a therapeutics
  developer and, as of this profile, exposes no public developer API, documentation, or developer portal; this entry captures
  its identity within the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/dewpoint/refs/heads/main/apis.yml
humanURL: https://dewpointx.com/
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Health Tech
- Biotech
- Drug Discovery
- Pharmaceuticals
- Life Sciences
- Machine-Learning
tags_raw:
- Company
- Health Tech
- Biotech
- Drug Discovery
- Pharmaceuticals
- Life Sciences
- Machine Learning
apis: []
common:
- type: Website
  url: https://dewpointx.com/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence